Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph L Sarow

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Cureus|April 11, 2025
Stage IV Prostate Cancer Presenting With a Low Prostate-Specific Antigen Level: A Case ReportBrandon Weissman, Joseph L Sarow, Sumi Singh, et al.
JCI Insight|May 22, 2020
β2-Adrenergic receptor activation on donor cells ameliorates acute GvHDHemn Mohammadpour, Joseph L Sarow, Cameron R MacDonald, et al.
Cell Reports|March 16, 2023
Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantationHemn Mohammadpour, Takemasa Tsuji, Cameron R MacDonald, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Cureus|April 11, 2025
Stage IV Prostate Cancer Presenting With a Low Prostate-Specific Antigen Level: A Case ReportBrandon Weissman, Joseph L Sarow, Sumi Singh, et al.
JCI Insight|May 22, 2020
β2-Adrenergic receptor activation on donor cells ameliorates acute GvHDHemn Mohammadpour, Joseph L Sarow, Cameron R MacDonald, et al.
Cell Reports|March 16, 2023
Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantationHemn Mohammadpour, Takemasa Tsuji, Cameron R MacDonald, et al.
Pageof 1